Wang Yue. Screening for primary aldosteronism in all hypertensive patients: inevitable strategy. [J]. Journal of Chongqing Medical University 46(9):1020-1022(2021)
DOI:
Wang Yue. Screening for primary aldosteronism in all hypertensive patients: inevitable strategy. [J]. Journal of Chongqing Medical University 46(9):1020-1022(2021) DOI: 10.13406/j.cnki.cyxb.002891.
Screening for primary aldosteronism in all hypertensive patients: inevitable strategy
Primary hyperaldosteronism (PA) accounts for 5%to 10%of all hypertensive patients. Screening is the first step of the diagnostic process of PA. Based on the latest evidences both at home and abroad
this manuscript puts forward the existing problems of screening and gives suggestions
in order to guide clinical work and improve the detection rate of PA.
Repeated measures-based comparison of patient-reported outcomes for patients with hypertension having different medication regimens and blood pressure levels
Echocardiographic changes in patients with acromegaly with hypertension and abnormal glucose metabolism
Degree of influence of hypertension and type 2 diabetes on early heart rate variability after cardiac bypass surgery
Appropriate technology for the hypertension management in the primary hospitals:an multi-center research
Influencing factors of hypertension control for hypertensive patients in community
Related Author
Tang Shunding
Zhang Wen
Deng Li
Song Ying
Wang Han
Zhang Xiaoqing
Zhang Ru
Li Haiyan
Related Institution
Chronic and Non-communicable Disease Prevention and Control Division,Baoshan Center for Disease Control and Prevention
Department of Cardiology, Fuwai Yunnan Cardiovascular Hospital
School of Public Health,Kunming Medical University
Department of Endocrinology,The Second Affiliated Hospital of Army Medical University
Department of Endocrinology,The First Affiliated Hospital of Army Medical University